EUVIMEDEUVIMED entdecken
LeserbriefKommentar

Piperacillin-Tazobactam vs Cefoxitin Prophylaxis for Pancreatoduodenectomy

Ziyi Yang, Jiawei Mei, Wei Gong

JAMA · 2023

DOI: 10.1001/jama.2023.12773 ↗

Kurz gefasst

Leserbrief in der Zeitschrift JAMA, 2023. Verfasst von Ziyi Yang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Cefoxitin, Pancreaticoduodenectomy, Piperacillin, Tazobactam Drug Combination, Antibiotic Prophylaxis. Die Arbeit nennt 4 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To the Editor A recent study1 found that antimicrobial prophylaxis with piperacillin-tazobactam was associated with lower rates of SSI and clinically relevant postoperative pancreatic fistula than cefoxitin in patients undergoing pancreatoduodenectomy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CefoxitinPancreaticoduodenectomyPiperacillin, Tazobactam Drug CombinationAntibiotic ProphylaxisAnti-Bacterial Agents

Substanzen

CefoxitinPiperacillin, Tazobactam Drug CombinationAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of General Surgery, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Zitieren

APA

Yang, Z., Mei, J., & Gong, W. (2023). Piperacillin-Tazobactam vs Cefoxitin Prophylaxis for Pancreatoduodenectomy. JAMA. https://doi.org/10.1001/jama.2023.12773

Vancouver

Yang Z, Mei J, Gong W. Piperacillin-Tazobactam vs Cefoxitin Prophylaxis for Pancreatoduodenectomy. JAMA. 2023. doi:10.1001/jama.2023.12773

BibTeX
@article{Yang2023,
  author = {Yang, Ziyi and Mei, Jiawei and Gong, Wei},
  title = {Piperacillin-Tazobactam vs Cefoxitin Prophylaxis for Pancreatoduodenectomy},
  journal = {JAMA},
  year = {2023},
  doi = {10.1001/jama.2023.12773}
}
Kostenlos starten →